Danger signals in stroke

Ageing Research Reviews

Volumn 24, Issue , 2015, Pages 77-82

  Gelderblom, Mathias ^a   Sobey, Christopher G ^b,c   Kleinschnitz, Christoph ^d   Magnus, Tim ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MONASH UNIVERSITY   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

DAMP; HMGB1; Hsp; Inflammation; Stroke

Indexed keywords

ADENOSINE TRIPHOSPHATE; DANGER ASSOCIATED MOLECULAR PATTERN; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; LIPID; PEPTIDES AND PROTEINS; PEROXIREDOXIN; PYRIMIDINE NUCLEOTIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AGING; BRAIN DAMAGE; BRAIN TISSUE; CEREBROVASCULAR ACCIDENT; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; REVIEW; THROMBOCYTE ACTIVATION; ANIMAL; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; HUMANS; STROKE;

EID: 84947032047     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2015.07.004     Document Type: Review

References (54)

1. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., Bianchi M.E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003, 22:5551-5560.
2. Chekeni F.B., Elliott M.R., Sandilos J.K., Walk S.F., Kinchen J.M., Lazarowski E.R., Armstrong A.J., Penuela S., Laird D.W., Salvesen G.S., Isakson B.E., Bayliss D.A., Ravichandran K.S. Pannexin 1 channels mediate "find-me" signal release and membrane permeability during apoptosis. Nature 2010, 467:863-867.
3. Davalos A.R., Kawahara M., Malhotra G.K., Schaum N., Huang J., Ved U., Beausejour C.M., Coppe J.P., Rodier F., Campisi J. p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J. Cell Biol. 2013, 201:613-629.
4. Doeppner T.R., Kaltwasser B., Fengyan J., Hermann D.M., Baehr M. TAT-Hsp70 induces neuroprotection against stroke via anti-inflammatory actions providing appropriate cellular microenvironment for transplantation of neural precursor cells. J. Cereb. Blood Flow Metab. 2013, 33:1778-1788.
5. Domercq M., Pérez-Samartín A., Aparicio D., Alberdi E., Pampliega O., Matute C. P2éíé7 receptors mediate ischemic damage to oligodendrocytes. Glia 2009, 15:730-740.
6. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nuñez G., Schnurr M., Espevik T., Lien E., Fitzgerald K.A., Rock K.L., Moore K.J., Wright S.D., Hornung V., Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 466:652.
7. Dumitriu I.E., Bianchi M.E., Bacci M., Manfredi A.A., Rovere-Querini P. The secretion of HMGB1 is required for the migration of maturing dendritic cells. J. Leukoc. Biol. 2006, 81:84-91.
8. Ellwood K.B., Yen Y.-M., Johnson R.C., Carey M. Mechanism for specificity by HMG-1 in enhance some assembly. Mol. Cell. Biol. 2000, 20:4359-4370.
9. Eltzschig H.K., Sitkovsky M.V., Robson S.C. Purinergic signaling during inflammation. N. Engl. J. Med. 2012, 367:2322-2333.
10. Friedman D.J., Künzli B.M., A-Rahim Y.I., Sevigny J., Berberat P.O., Enjyoji K., Csizmadia E., Friess H., Robson S.C. CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(16):788-16793.
11. Gelderblom M., Weymar A., Bernreuther C., Velden J., Arunachalam P., Steinbach K., Orthey E., Arumugam T.V., Leypoldt F., Simova O., Thom V., Friese M.A., Prinz I., Holscher C., Glatzel M., Korn T., Gerloff C., Tolosa E., Magnus T. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 2012, 120:3793-3802.
12. Gelderblom M., Leypoldt F., Steinbach K., Behrens D., Choe C.U., Siler D.A., Arumugam T.V., Orthey E., Gerloff C., Tolosa E., Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857.
13. Gong G., Xiang L., Yuan L., Hu L., Wu W., Cai L., Yin L., Dong H. Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats. PLoS One 2014, 9:e89450.
14. Hanschmann A.M., Godoy J.R., Berndt C., Hudemann C., Lillig C.H. Thioredoxins, glutaredoxins, and peroxiredoxins-molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid. Redox Signaling 2013, 19:1539-1605.
15. Hayakawa K., Pham L.-D.D., Arai K., Lo E.H. High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke. Acta Neurochir. Suppl. 2013, 118:31-38.
16. Hayakawa K., Pham L.-D.D., Arai K., Lo E.H. Reactive astrocytes promote adhesive interactions between brain endothelium and endothelial progenitor cells via HMGB1 and beta-2 integrin signaling. Stem Cell Res. 2014, 12:531-538.
17. Hayakawa K., Qiu J., Lo E.H. Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann. N. Y. Acad. Sci. 2010, 1207:50-57.
18. Huttunen H.J., Kuja-Panula J., Rauvala H. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J. Biol. Chem. 2002, 277(38):635-38646.
19. Hyman M.C., Petrovic-Djergovic D., Visovatti S.H., Liao H., Yanamadala S., Bouïs D., Su E.J., Lawrence D.A., Broekman M.J., Marcus A.J., Pinsky D.J. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J. Clin. Invest. 2009, 119:1136-1149.
20. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation. Nat. Med. 2011, 17:796-808.
21. Kim J.B. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. 2006, 26:6413-6421.
22. Kim J.Y., Yenari M.A. The immune modulating properties of the heat shock proteins after brain injury. Anat. Cell Biol. 2013, 46:1-7.
23. Kleinschnitz C., Kraft P., Dreykluft A., Hagedorn I., Göbel K., Schuhmann M.K., Langhauser F., Helluy X., Schwarz T., Bittner S., Mayer C.T., Brede M., Varallyay C., Pham M., Bendszus M., Jakob P., Magnus T., Meuth S.G., Iwakura Y., Zernecke A., Sparwasser T., Nieswandt B., Stoll G., Wiendl H. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2013, 121:679-691.
24. Kleinschnitz C., Schwab N., Kraft P., Hagedorn I., Dreykluft A., Schwarz T., Austinat M., Nieswandt B., Wiendl H., Stoll G. Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 2010, 115:3835-3842.
25. Koizumi S., Shigemoto-Mogami Y., Nasu-Tada K., Shinozaki Y., Ohsawa K., Tsuda M., Joshi B.V., Jacobson K.A., Kohsaka S., Inoue K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007, 446:1091-1095.
26. Krizhanovsky V., Yon M., Dickins R.A., Hearn S., Simon J., Miething C., Yee H., Zender L., Lowe S.W. Senescence of activated stellate cells limits liver fibrosis. Cell 2008, 134:657-667.
27. Li S., Zheng J., Carmichael S.T. Increased oxidative protein and DNA damage but decreased stress response in the aged brain following experimental stroke. Neurobiol. Dis. 2005, 18:432-440.
28. Liesz A., Dalpke A., Mracsko E., Antoine D.J., Roth S., Zhou W., Yang H., Na S.Y., Akhisaroglu M., Fleming T., Eigenbrod T., Nawroth P.P., Tracey K.J., Veltkamp R. DAMP signaling is a key pathway inducing immune modulation after brain injury. J. Neurosci. 2015, 35:583-598.
29. Manaenko A., Fathali N., Chen H., Suzuki H., Williams S., Zhang J.H., Tang J. Heat shock protein 70 upregulation by geldanamycin reduces brain injury in a mouse model of intracerebral hemorrhage. Neurochem. Int. 2010, 57:844-850.
30. Mezayen El R., Gazzar El M., Myer R., High K.P. Aging-dependent upregulation of IL-23p19 gene expression in dendritic cells is associated with differential transcription factor binding and histone modifications. Aging Cell 2009, 8:553-565.
31. Muhammad S., Barakat W., Stoyanov S., Murikinati S., Yang H., Tracey K.J., Bendszus M., Rossetti G., Nawroth P.P., Bierhaus A., Schwaninger M. The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 2008, 28:12023-12031.
32. Petrovic-Djergovic D., Hyman M.C., Ray J.J., Bouis D., Visovatti S.H., Hayasaki T., Pinsky D.J. Tissue-resident Ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ichemic brain. J. Immunol. 2012, 188:2387-2398.
33. Planas A.M., Gorina R., Chamorro A. Signalling pathways mediating inflammatory responses in brain ischaemia. BioChem. Soc. Trans. 2006, 34:1267-1270.
34. Qiu J., Nishimura M., Wang Y., Sims J.R., Qiu S., Savitz S.I., Salomone S., Moskowitz M.A. Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28:927-938.
35. Qteishat, Al A., Gaffney J., Krupinski J., Rubio F., West D., Kumar S., Kumar P., Mitsios N., Slevin M. Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain 2006, 129:2158-2176.
36. Qteishat, Al A., Gaffney J.J., Krupinski J., Slevin M. Hyaluronan expression following middle cerebral artery occlusion in the rat. Neuroreport 2006, 17:1111-1114.
37. Riegel A.-K., Faigle M., Zug S., Rosenberger P., Robaye B., Boeynaems J.-M., Idzko M., Eltzschig H.K. Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood 2011, 117:2548-2555.
38. Schlueter C., Weber H., Meyer B., Rogalla P., Röser K., Hauke S., Bullerdiek J. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am. J. Pathol. 2005, 166:1259-1263.
39. Semino C., Angelini G., Poggi A., Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 2005, 106:609-616.
40. Sharp F.R., Zhan X., Liu D.-Z. Heat shock proteins in the brain: role of Hsp70, Hsp 27, and HO-1 (Hsp32) and their therapeutic potential. Transl. Stroke Res. 2013, 4:685-692.
41. Shaw A.C., Goldstein D.R., Montgomery R.R. Age-dependent dysregulation of innate immunity. Nat. Rev. Immunol. 2013, 13:875-887.
42. Shichita T., Ito M., Yoshimura A. Post-ischemic inflammation regulates neural damage and protection. Front. Cell. Neurosci. 2014, 10.3389/fncel.2014.00319/abstract.
43. Shichita T., Hasegawa E., Kimura A., Morita R., Sakaguchi R., Takada I., Sekiya T., Ooboshi H., Kitazono T., Yanagawa T., Ishii T., Takahashi H., Mori S., Nishibori M., Kuroda K., Akira S., Miyake K., Yoshimura A. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med. 2012, 18:911-917.
44. Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I., Iwaki T., Okada Y., Iida M., Cua D.J., Iwakura Y., Yoshimura A. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med. 2009, 15:946-950.
45. Sundberg E., Fasth A.E.R., Palmblad K., Harris H.E., Andersson U. High mobility group box chromosomal protein 1 acts as a proliferation signal for activated T lymphocytes. Immunobiology 2009, 214:303-309. 10.1016/j.imbio.2008.09.006.
46. Tang S.-C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.-G., Lathia J.D., Siler D.A., Chigurupati S., Ouyang X., Magnus T., Camandola S., Mattson M.P. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(13):798-13803.
47. Tang S.-C., Wang Y.-C., Li Y.-I., Lin H.-C., Manzanero S., Hsieh Y.-H., Phipps S., Hu C.-J., Chiou H.-Y., Huang Y.-S., Yang W.-S., Mattson M.P., Arumugam T.V., Jeng J.-S. Functional role of soluble receptor for advanced glycation end products in stroke. Arterioscler. Thromb. Vasc. Biol. 2013, 33:585-594.
48. Wang Z., Nakayama T., Sato N., Yamaguchi M., Izumi Y., Kasamaki Y., Ohta M., Soma M., Aoi N., Ozawa Y., Ma Y., Doba N., Hinohara S. Purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene is associated with cerebral infarction in Japanese subjects. Hypertens. Res. 2009, 32:989-996.
49. Webster C.M., Hokari M., McManus A., Tang X.N., Ma H., Kacimi R., Yenari M.A. Microglial P2Y12 deficiency/inhibition protects against brain ischemia 8. PLoS One 2013, e70927.
50. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007, 445:656-660.
51. Yashiro K., Matsumoto Y., Ihara H., Suzuki Y., Kondo K., Urano T., Umemura K. Involvement of platelet activation by P2Y12 receptor in the development of transplant arteriosclerosis in mice. Transplantation 2009, 87:660-667.
52. Yilmaz G., Arumugam T.V., Stokes K.Y., Granger D.N. Role of T lymphocytes and interferon-γ in ischemic stroke. Circulation 2006, 113:2105-2112.
53. Zhan X., Ander B.P., Liao I.H., Hansen J.E., Kim C., Clements D., Weisbart R.H., Nishimura R.N., Sharp F.R. Recombinant Fv-Hsp70 protein mediates neuroprotection after focal cerebral ischemia in rats. Stroke 2010, 41:538-543.
54. Zheng Z., Kim J.Y., Ma H., Lee J.E., Yenari M.A. Anti-inflammatory effects of the 70kDa heat shock protein in experimental stroke. J. Cereb. Blood Flow Metab. 2007, 28:53-63.